UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Antiviral agents | General aspects | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Lymphoma | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 981 - 988
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Proto-Oncogene Proteins - genetics | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Taxoids - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged, 80 and over | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Care and treatment | Chemotherapy | Erlotinib | Clinical trials | Lung cancer, Non-small cell | Tumors | Cancer | Index Medicus
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 4, Issue 1, pp. e15 - e23
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Hematology | Science & Technology | Bendamustine Hydrochloride - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bendamustine Hydrochloride - adverse effects | Cytarabine - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cytarabine - adverse effects | Cytarabine - administration & dosage | Rituximab - administration & dosage | Rituximab - therapeutic use | Bendamustine Hydrochloride - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Female | Italy - epidemiology | Aged | Lymphoma, Mantle-Cell - epidemiology | Rituximab - adverse effects | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2020, Volume 395, Issue 10239, pp. 1771 - 1778
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pandemics | Humans | Child, Preschool | Male | Mucocutaneous Lymph Node Syndrome - epidemiology | COVID-19 | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Disease Outbreaks | Betacoronavirus | Female | Italy | Retrospective Studies | Child | Epidemics | Analysis | Severe acute respiratory syndrome | Coronaviruses | Children | Health aspects | Diseases | Immunoglobulin M | Laboratories | Pathogenesis | Immunoglobulin G | Viral diseases | Clinical trials | Viruses | Outbreaks | Infections | Arthritis | Macrophages | Blood | Cell activation | Ultrasonic imaging | Kawasaki disease | Heart diseases | Medical research | Immunoglobulins | Statistical analysis | Immune response | Rheumatology | Vital signs | Coronary artery disease | Girls | Fever | Severe acute respiratory syndrome coronavirus 2 | Heart rate | Hospitals | Respiratory diseases | Mucocutaneous lymph node syndrome | Erythema | Steroids | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 5548 - 5548
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 06/2012, Volume 61, Issue 6, pp. 1633 - 1641
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Cardiology. Vascular system | Heart | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Endocrine pancreas. Apud cells (diseases) | Myocardial Ischemia - genetics | Myocardial Ischemia - metabolism | Diabetic Cardiomyopathies - metabolism | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Heart Failure - genetics | Male | MicroRNAs - metabolism | Heart Failure - metabolism | Diabetes Mellitus, Type 2 - metabolism | Diabetic Cardiomyopathies - genetics | Myocardium - metabolism | Myocytes, Cardiac - metabolism | Female | Aged | MicroRNAs - genetics | Heart failure | Physiological aspects | Care and treatment | Genetic aspects | MicroRNA | Research | Index Medicus | Abridged Index Medicus | Metabolomics | Genetics | Genomes | Proteomics
Journal Article
7.
Full Text
An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210
The Journal of biological chemistry, ISSN 0021-9258, 12/2009, Volume 284, Issue 50, pp. 35134 - 35143
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Animals | Base Sequence | Humans | Cells, Cultured | Gene Expression Regulation | MicroRNAs - metabolism | Gene Expression Profiling | MicroRNAs - genetics | Proteome - analysis | Proteomics - methods | Cluster Analysis | Hypoxia - metabolism | Index Medicus | RNA-Mediated Regulation and Noncoding RNAs
Journal Article
8.
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: Analysis of 75 patients
Journal of clinical oncology, ISSN 0732-183X, 04/1999, Volume 17, Issue 4, pp. 1254 - 1258
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Humans | Middle Aged | Interferon-alpha - therapeutic use | Lymphoma, B-Cell, Marginal Zone - therapy | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Lymphoma, B-Cell, Marginal Zone - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 12/2012, Volume 287, Issue 53, pp. 44761 - 44771
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cell Line | Promoter Regions, Genetic | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Molecular Sequence Data | Male | MicroRNAs - metabolism | Oxygen - metabolism | Myoblasts - metabolism | Animals | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Base Sequence | Myoblasts - cytology | Cell Differentiation | Mice | MicroRNAs - genetics | Index Medicus | Gene Regulation | Hif1a | Skeletal Muscle | Oxidative Stress | miR-210 | Cell Death | Promoters
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2016
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2006, Volume 24, Issue 9, pp. 1376 - 1382
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Skin Neoplasms - pathology | Prognosis | Skin Neoplasms - drug therapy | Skin Neoplasms - radiotherapy | Humans | Middle Aged | Lymphoma, B-Cell - radiotherapy | Male | Treatment Outcome | Lymphoma, B-Cell - classification | Skin Neoplasms - classification | Disease-Free Survival | Lymphoma, B-Cell - pathology | Female | Aged | Retrospective Studies | Neoplasm Staging | Lymphoma, B-Cell - drug therapy | Index Medicus
Journal Article